0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Semi-synthetic β-lactam Antibiotics Market Research Report 2026
Published Date: 2026-02-06
|
Report Code: QYRE-Auto-35A19796
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Semi synthetic β lactam Antibiotics Market Outlook In Depth Analysis Forecast to 2031
BUY CHAPTERS

Global Semi-synthetic β-lactam Antibiotics Market Research Report 2026

Code: QYRE-Auto-35A19796
Report
2026-02-06
Pages:131
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Semi-synthetic β-lactam Antibiotics Market

The global Semi-synthetic β-lactam Antibiotics market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Semi-synthetic β-lactam Antibiotics competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Semi-synthetic β-lactam antibiotics refer to β-lactam antibiotics produced by combining chemical synthesis with natural antibiotic molecules. These antibiotics include penicillins and cephalosporins, characterized by their β-lactam ring structure. They are typically synthesized using naturally derived 6-aminopenicillanic acid (6-APA) or 7-aminocephalosporanic acid (7-ACA) as starting materials, which are chemically modified by adding different side chains to create antibiotics with specific antibacterial spectrums. Common semi-synthetic β-lactam antibiotics include amoxicillin, cephalexin, and others.
The North American market for Semi-synthetic β-lactam Antibiotics is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Semi-synthetic β-lactam Antibiotics is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
Major global manufacturers of Semi-synthetic β-lactam Antibiotics include GSK, Novartis, Centrient Pharma, Teva, Mylan, Cipla, Huayao International, United Pharmaceuticals, Sun Pharma, Lukang Pharmaceuticals, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Semi-synthetic β-lactam Antibiotics market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Semi-synthetic β-lactam Antibiotics. The Semi-synthetic β-lactam Antibiotics market size, estimates, and forecasts are provided in terms of sales volume (Tons) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Semi-synthetic β-lactam Antibiotics market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Semi-synthetic β-lactam Antibiotics manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Semi-synthetic β-lactam Antibiotics Market Report

Report Metric Details
Report Name Semi-synthetic β-lactam Antibiotics Market
Segment by Type
  • Penicillin and Its Derivatives
  • Cephalosporins
  • Other
by Application
  • Hospital
  • Clinic
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company GSK, Novartis, Centrient Pharma, Teva, Mylan, Cipla, Huayao International, United Pharmaceuticals, Sun Pharma, Lukang Pharmaceuticals, Hikma, Dr. Reddy, Harbin Pharmaceuticals, Aurubindo, Meiji Holdings, DSM, Changsheng Pharmaceuticals, North China Pharmaceuticals, Chuanning Biopharmaceuticals, Weiqida
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Semi-synthetic β-lactam Antibiotics manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Semi-synthetic β-lactam Antibiotics sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

Who are the main players in the Semi-synthetic β-lactam Antibiotics Market report?

Ans: The main players in the Semi-synthetic β-lactam Antibiotics Market are GSK, Novartis, Centrient Pharma, Teva, Mylan, Cipla, Huayao International, United Pharmaceuticals, Sun Pharma, Lukang Pharmaceuticals, Hikma, Dr. Reddy, Harbin Pharmaceuticals, Aurubindo, Meiji Holdings, DSM, Changsheng Pharmaceuticals, North China Pharmaceuticals, Chuanning Biopharmaceuticals, Weiqida

What are the Application segmentation covered in the Semi-synthetic β-lactam Antibiotics Market report?

Ans: The Applications covered in the Semi-synthetic β-lactam Antibiotics Market report are Hospital, Clinic, Other

What are the Type segmentation covered in the Semi-synthetic β-lactam Antibiotics Market report?

Ans: The Types covered in the Semi-synthetic β-lactam Antibiotics Market report are Penicillin and Its Derivatives, Cephalosporins, Other

1 Semi-synthetic β-lactam Antibiotics Market Overview
1.1 Product Definition
1.2 Semi-synthetic β-lactam Antibiotics by Type
1.2.1 Global Semi-synthetic β-lactam Antibiotics Market Value by Type: 2025 vs 2032
1.2.2 Penicillin and Its Derivatives
1.2.3 Cephalosporins
1.2.4 Other
1.3 Semi-synthetic β-lactam Antibiotics by Application
1.3.1 Global Semi-synthetic β-lactam Antibiotics Market Value by Application: 2025 vs 2032
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global Semi-synthetic β-lactam Antibiotics Market Size Estimates and Forecasts
1.4.1 Global Semi-synthetic β-lactam Antibiotics Revenue 2021–2032
1.4.2 Global Semi-synthetic β-lactam Antibiotics Sales 2021–2032
1.4.3 Global Semi-synthetic β-lactam Antibiotics Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Semi-synthetic β-lactam Antibiotics Market Competition by Manufacturers
2.1 Global Semi-synthetic β-lactam Antibiotics Sales Market Share by Manufacturers (2021–2026)
2.2 Global Semi-synthetic β-lactam Antibiotics Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Semi-synthetic β-lactam Antibiotics Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Semi-synthetic β-lactam Antibiotics, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Semi-synthetic β-lactam Antibiotics, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Semi-synthetic β-lactam Antibiotics, Product Types and Applications
2.7 Global Key Manufacturers of Semi-synthetic β-lactam Antibiotics, Date of Entry into the Industry
2.8 Global Semi-synthetic β-lactam Antibiotics Market Competitive Situation and Trends
2.8.1 Global Semi-synthetic β-lactam Antibiotics Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Semi-synthetic β-lactam Antibiotics Players Market Share by Revenue
2.8.3 Global Semi-synthetic β-lactam Antibiotics Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Semi-synthetic β-lactam Antibiotics Market Scenario by Region
3.1 Global Semi-synthetic β-lactam Antibiotics Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Semi-synthetic β-lactam Antibiotics Sales by Region: 2021–2032
3.2.1 Global Semi-synthetic β-lactam Antibiotics Sales by Region: 2021–2026
3.2.2 Global Semi-synthetic β-lactam Antibiotics Sales by Region: 2027–2032
3.3 Global Semi-synthetic β-lactam Antibiotics Revenue by Region: 2021–2032
3.3.1 Global Semi-synthetic β-lactam Antibiotics Revenue by Region: 2021–2026
3.3.2 Global Semi-synthetic β-lactam Antibiotics Revenue by Region: 2027–2032
3.4 North America Semi-synthetic β-lactam Antibiotics Market Facts & Figures by Country
3.4.1 North America Semi-synthetic β-lactam Antibiotics Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Semi-synthetic β-lactam Antibiotics Sales by Country (2021–2032)
3.4.3 North America Semi-synthetic β-lactam Antibiotics Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Semi-synthetic β-lactam Antibiotics Market Facts & Figures by Country
3.5.1 Europe Semi-synthetic β-lactam Antibiotics Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Semi-synthetic β-lactam Antibiotics Sales by Country (2021–2032)
3.5.3 Europe Semi-synthetic β-lactam Antibiotics Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Semi-synthetic β-lactam Antibiotics Market Facts & Figures by Region
3.6.1 Asia Pacific Semi-synthetic β-lactam Antibiotics Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Semi-synthetic β-lactam Antibiotics Sales by Region (2021–2032)
3.6.3 Asia Pacific Semi-synthetic β-lactam Antibiotics Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Semi-synthetic β-lactam Antibiotics Market Facts & Figures by Country
3.7.1 Latin America Semi-synthetic β-lactam Antibiotics Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Semi-synthetic β-lactam Antibiotics Sales by Country (2021–2032)
3.7.3 Latin America Semi-synthetic β-lactam Antibiotics Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Semi-synthetic β-lactam Antibiotics Market Facts & Figures by Country
3.8.1 Middle East and Africa Semi-synthetic β-lactam Antibiotics Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Semi-synthetic β-lactam Antibiotics Sales by Country (2021–2032)
3.8.3 Middle East and Africa Semi-synthetic β-lactam Antibiotics Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Semi-synthetic β-lactam Antibiotics Sales by Type (2021–2032)
4.1.1 Global Semi-synthetic β-lactam Antibiotics Sales by Type (2021–2026)
4.1.2 Global Semi-synthetic β-lactam Antibiotics Sales by Type (2027–2032)
4.1.3 Global Semi-synthetic β-lactam Antibiotics Sales Market Share by Type (2021–2032)
4.2 Global Semi-synthetic β-lactam Antibiotics Revenue by Type (2021–2032)
4.2.1 Global Semi-synthetic β-lactam Antibiotics Revenue by Type (2021–2026)
4.2.2 Global Semi-synthetic β-lactam Antibiotics Revenue by Type (2027–2032)
4.2.3 Global Semi-synthetic β-lactam Antibiotics Revenue Market Share by Type (2021–2032)
4.3 Global Semi-synthetic β-lactam Antibiotics Price by Type (2021–2032)
5 Segment by Application
5.1 Global Semi-synthetic β-lactam Antibiotics Sales by Application (2021–2032)
5.1.1 Global Semi-synthetic β-lactam Antibiotics Sales by Application (2021–2026)
5.1.2 Global Semi-synthetic β-lactam Antibiotics Sales by Application (2027–2032)
5.1.3 Global Semi-synthetic β-lactam Antibiotics Sales Market Share by Application (2021–2032)
5.2 Global Semi-synthetic β-lactam Antibiotics Revenue by Application (2021–2032)
5.2.1 Global Semi-synthetic β-lactam Antibiotics Revenue by Application (2021–2026)
5.2.2 Global Semi-synthetic β-lactam Antibiotics Revenue by Application (2027–2032)
5.2.3 Global Semi-synthetic β-lactam Antibiotics Revenue Market Share by Application (2021–2032)
5.3 Global Semi-synthetic β-lactam Antibiotics Price by Application (2021–2032)
6 Key Companies Profiled
6.1 GSK
6.1.1 GSK Company Information
6.1.2 GSK Description and Business Overview
6.1.3 GSK Semi-synthetic β-lactam Antibiotics Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 GSK Semi-synthetic β-lactam Antibiotics Product Portfolio
6.1.5 GSK Recent Developments/Updates
6.2 Novartis
6.2.1 Novartis Company Information
6.2.2 Novartis Description and Business Overview
6.2.3 Novartis Semi-synthetic β-lactam Antibiotics Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Novartis Semi-synthetic β-lactam Antibiotics Product Portfolio
6.2.5 Novartis Recent Developments/Updates
6.3 Centrient Pharma
6.3.1 Centrient Pharma Company Information
6.3.2 Centrient Pharma Description and Business Overview
6.3.3 Centrient Pharma Semi-synthetic β-lactam Antibiotics Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Centrient Pharma Semi-synthetic β-lactam Antibiotics Product Portfolio
6.3.5 Centrient Pharma Recent Developments/Updates
6.4 Teva
6.4.1 Teva Company Information
6.4.2 Teva Description and Business Overview
6.4.3 Teva Semi-synthetic β-lactam Antibiotics Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Teva Semi-synthetic β-lactam Antibiotics Product Portfolio
6.4.5 Teva Recent Developments/Updates
6.5 Mylan
6.5.1 Mylan Company Information
6.5.2 Mylan Description and Business Overview
6.5.3 Mylan Semi-synthetic β-lactam Antibiotics Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Mylan Semi-synthetic β-lactam Antibiotics Product Portfolio
6.5.5 Mylan Recent Developments/Updates
6.6 Cipla
6.6.1 Cipla Company Information
6.6.2 Cipla Description and Business Overview
6.6.3 Cipla Semi-synthetic β-lactam Antibiotics Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Cipla Semi-synthetic β-lactam Antibiotics Product Portfolio
6.6.5 Cipla Recent Developments/Updates
6.7 Huayao International
6.7.1 Huayao International Company Information
6.7.2 Huayao International Description and Business Overview
6.7.3 Huayao International Semi-synthetic β-lactam Antibiotics Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Huayao International Semi-synthetic β-lactam Antibiotics Product Portfolio
6.7.5 Huayao International Recent Developments/Updates
6.8 United Pharmaceuticals
6.8.1 United Pharmaceuticals Company Information
6.8.2 United Pharmaceuticals Description and Business Overview
6.8.3 United Pharmaceuticals Semi-synthetic β-lactam Antibiotics Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 United Pharmaceuticals Semi-synthetic β-lactam Antibiotics Product Portfolio
6.8.5 United Pharmaceuticals Recent Developments/Updates
6.9 Sun Pharma
6.9.1 Sun Pharma Company Information
6.9.2 Sun Pharma Description and Business Overview
6.9.3 Sun Pharma Semi-synthetic β-lactam Antibiotics Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Sun Pharma Semi-synthetic β-lactam Antibiotics Product Portfolio
6.9.5 Sun Pharma Recent Developments/Updates
6.10 Lukang Pharmaceuticals
6.10.1 Lukang Pharmaceuticals Company Information
6.10.2 Lukang Pharmaceuticals Description and Business Overview
6.10.3 Lukang Pharmaceuticals Semi-synthetic β-lactam Antibiotics Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Lukang Pharmaceuticals Semi-synthetic β-lactam Antibiotics Product Portfolio
6.10.5 Lukang Pharmaceuticals Recent Developments/Updates
6.11 Hikma
6.11.1 Hikma Company Information
6.11.2 Hikma Description and Business Overview
6.11.3 Hikma Semi-synthetic β-lactam Antibiotics Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Hikma Semi-synthetic β-lactam Antibiotics Product Portfolio
6.11.5 Hikma Recent Developments/Updates
6.12 Dr. Reddy
6.12.1 Dr. Reddy Company Information
6.12.2 Dr. Reddy Description and Business Overview
6.12.3 Dr. Reddy Semi-synthetic β-lactam Antibiotics Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Dr. Reddy Semi-synthetic β-lactam Antibiotics Product Portfolio
6.12.5 Dr. Reddy Recent Developments/Updates
6.13 Harbin Pharmaceuticals
6.13.1 Harbin Pharmaceuticals Company Information
6.13.2 Harbin Pharmaceuticals Description and Business Overview
6.13.3 Harbin Pharmaceuticals Semi-synthetic β-lactam Antibiotics Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 Harbin Pharmaceuticals Semi-synthetic β-lactam Antibiotics Product Portfolio
6.13.5 Harbin Pharmaceuticals Recent Developments/Updates
6.14 Aurubindo
6.14.1 Aurubindo Company Information
6.14.2 Aurubindo Description and Business Overview
6.14.3 Aurubindo Semi-synthetic β-lactam Antibiotics Sales, Revenue, and Gross Margin (2021–2026)
6.14.4 Aurubindo Semi-synthetic β-lactam Antibiotics Product Portfolio
6.14.5 Aurubindo Recent Developments/Updates
6.15 Meiji Holdings
6.15.1 Meiji Holdings Company Information
6.15.2 Meiji Holdings Description and Business Overview
6.15.3 Meiji Holdings Semi-synthetic β-lactam Antibiotics Sales, Revenue, and Gross Margin (2021–2026)
6.15.4 Meiji Holdings Semi-synthetic β-lactam Antibiotics Product Portfolio
6.15.5 Meiji Holdings Recent Developments/Updates
6.16 DSM
6.16.1 DSM Company Information
6.16.2 DSM Description and Business Overview
6.16.3 DSM Semi-synthetic β-lactam Antibiotics Sales, Revenue, and Gross Margin (2021–2026)
6.16.4 DSM Semi-synthetic β-lactam Antibiotics Product Portfolio
6.16.5 DSM Recent Developments/Updates
6.17 Changsheng Pharmaceuticals
6.17.1 Changsheng Pharmaceuticals Company Information
6.17.2 Changsheng Pharmaceuticals Description and Business Overview
6.17.3 Changsheng Pharmaceuticals Semi-synthetic β-lactam Antibiotics Sales, Revenue, and Gross Margin (2021–2026)
6.17.4 Changsheng Pharmaceuticals Semi-synthetic β-lactam Antibiotics Product Portfolio
6.17.5 Changsheng Pharmaceuticals Recent Developments/Updates
6.18 North China Pharmaceuticals
6.18.1 North China Pharmaceuticals Company Information
6.18.2 North China Pharmaceuticals Description and Business Overview
6.18.3 North China Pharmaceuticals Semi-synthetic β-lactam Antibiotics Sales, Revenue, and Gross Margin (2021–2026)
6.18.4 North China Pharmaceuticals Semi-synthetic β-lactam Antibiotics Product Portfolio
6.18.5 North China Pharmaceuticals Recent Developments/Updates
6.19 Chuanning Biopharmaceuticals
6.19.1 Chuanning Biopharmaceuticals Company Information
6.19.2 Chuanning Biopharmaceuticals Description and Business Overview
6.19.3 Chuanning Biopharmaceuticals Semi-synthetic β-lactam Antibiotics Sales, Revenue, and Gross Margin (2021–2026)
6.19.4 Chuanning Biopharmaceuticals Semi-synthetic β-lactam Antibiotics Product Portfolio
6.19.5 Chuanning Biopharmaceuticals Recent Developments/Updates
6.20 Weiqida
6.20.1 Weiqida Company Information
6.20.2 Weiqida Description and Business Overview
6.20.3 Weiqida Semi-synthetic β-lactam Antibiotics Sales, Revenue, and Gross Margin (2021–2026)
6.20.4 Weiqida Semi-synthetic β-lactam Antibiotics Product Portfolio
6.20.5 Weiqida Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Semi-synthetic β-lactam Antibiotics Industry Chain Analysis
7.2 Semi-synthetic β-lactam Antibiotics Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Semi-synthetic β-lactam Antibiotics Production Mode & Process Analysis
7.4 Semi-synthetic β-lactam Antibiotics Sales and Marketing
7.4.1 Semi-synthetic β-lactam Antibiotics Sales Channels
7.4.2 Semi-synthetic β-lactam Antibiotics Distributors
7.5 Semi-synthetic β-lactam Antibiotics Customer Analysis
8 Semi-synthetic β-lactam Antibiotics Market Dynamics
8.1 Semi-synthetic β-lactam Antibiotics Industry Trends
8.2 Semi-synthetic β-lactam Antibiotics Market Drivers
8.3 Semi-synthetic β-lactam Antibiotics Market Challenges
8.4 Semi-synthetic β-lactam Antibiotics Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Semi-synthetic β-lactam Antibiotics Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Semi-synthetic β-lactam Antibiotics Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global Semi-synthetic β-lactam Antibiotics Market Competitive Situation by Manufacturers in 2025
 Table 4. Global Semi-synthetic β-lactam Antibiotics Sales (Tons) of Key Manufacturers (2021–2026)
 Table 5. Global Semi-synthetic β-lactam Antibiotics Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global Semi-synthetic β-lactam Antibiotics Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global Semi-synthetic β-lactam Antibiotics Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market Semi-synthetic β-lactam Antibiotics Average Price (US$/Ton) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of Semi-synthetic β-lactam Antibiotics, Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of Semi-synthetic β-lactam Antibiotics, Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of Semi-synthetic β-lactam Antibiotics, Product Types and Applications
 Table 12. Global Key Manufacturers of Semi-synthetic β-lactam Antibiotics, Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Semi-synthetic β-lactam Antibiotics Companies by Tier (Tier 1, Tier 2, Tier 3), based on Semi-synthetic β-lactam Antibiotics Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Semi-synthetic β-lactam Antibiotics Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global Semi-synthetic β-lactam Antibiotics Sales by Region (Tons), 2021–2026
 Table 18. Global Semi-synthetic β-lactam Antibiotics Sales Market Share by Region (2021–2026)
 Table 19. Global Semi-synthetic β-lactam Antibiotics Sales by Region (Tons), 2027–2032
 Table 20. Global Semi-synthetic β-lactam Antibiotics Sales Market Share by Region (2027–2032)
 Table 21. Global Semi-synthetic β-lactam Antibiotics Revenue by Region (US$ Million), 2021–2026
 Table 22. Global Semi-synthetic β-lactam Antibiotics Revenue Market Share by Region (2021–2026)
 Table 23. Global Semi-synthetic β-lactam Antibiotics Revenue by Region (US$ Million), 2027–2032
 Table 24. Global Semi-synthetic β-lactam Antibiotics Revenue Market Share by Region (2027–2032)
 Table 25. North America Semi-synthetic β-lactam Antibiotics Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America Semi-synthetic β-lactam Antibiotics Sales by Country (Tons), 2021–2026
 Table 27. North America Semi-synthetic β-lactam Antibiotics Sales by Country (Tons), 2027–2032
 Table 28. North America Semi-synthetic β-lactam Antibiotics Revenue by Country (US$ Million), 2021–2026
 Table 29. North America Semi-synthetic β-lactam Antibiotics Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe Semi-synthetic β-lactam Antibiotics Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe Semi-synthetic β-lactam Antibiotics Sales by Country (Tons), 2021–2026
 Table 32. Europe Semi-synthetic β-lactam Antibiotics Sales by Country (Tons), 2027–2032
 Table 33. Europe Semi-synthetic β-lactam Antibiotics Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe Semi-synthetic β-lactam Antibiotics Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific Semi-synthetic β-lactam Antibiotics Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific Semi-synthetic β-lactam Antibiotics Sales by Region (Tons), 2021–2026
 Table 37. Asia Pacific Semi-synthetic β-lactam Antibiotics Sales by Region (Tons), 2027–2032
 Table 38. Asia Pacific Semi-synthetic β-lactam Antibiotics Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific Semi-synthetic β-lactam Antibiotics Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America Semi-synthetic β-lactam Antibiotics Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America Semi-synthetic β-lactam Antibiotics Sales by Country (Tons), 2021–2026
 Table 42. Latin America Semi-synthetic β-lactam Antibiotics Sales by Country (Tons), 2027–2032
 Table 43. Latin America Semi-synthetic β-lactam Antibiotics Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America Semi-synthetic β-lactam Antibiotics Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa Semi-synthetic β-lactam Antibiotics Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa Semi-synthetic β-lactam Antibiotics Sales by Country (Tons), 2021–2026
 Table 47. Middle East and Africa Semi-synthetic β-lactam Antibiotics Sales by Country (Tons), 2027–2032
 Table 48. Middle East and Africa Semi-synthetic β-lactam Antibiotics Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa Semi-synthetic β-lactam Antibiotics Revenue by Country (US$ Million), 2027–2032
 Table 50. Global Semi-synthetic β-lactam Antibiotics Sales (Tons) by Type (2021–2026)
 Table 51. Global Semi-synthetic β-lactam Antibiotics Sales (Tons) by Type (2027–2032)
 Table 52. Global Semi-synthetic β-lactam Antibiotics Sales Market Share by Type (2021–2026)
 Table 53. Global Semi-synthetic β-lactam Antibiotics Sales Market Share by Type (2027–2032)
 Table 54. Global Semi-synthetic β-lactam Antibiotics Revenue (US$ Million) by Type (2021–2026)
 Table 55. Global Semi-synthetic β-lactam Antibiotics Revenue (US$ Million) by Type (2027–2032)
 Table 56. Global Semi-synthetic β-lactam Antibiotics Revenue Market Share by Type (2021–2026)
 Table 57. Global Semi-synthetic β-lactam Antibiotics Revenue Market Share by Type (2027–2032)
 Table 58. Global Semi-synthetic β-lactam Antibiotics Price (US$/Ton) by Type (2021–2026)
 Table 59. Global Semi-synthetic β-lactam Antibiotics Price (US$/Ton) by Type (2027–2032)
 Table 60. Global Semi-synthetic β-lactam Antibiotics Sales (Tons) by Application (2021–2026)
 Table 61. Global Semi-synthetic β-lactam Antibiotics Sales (Tons) by Application (2027–2032)
 Table 62. Global Semi-synthetic β-lactam Antibiotics Sales Market Share by Application (2021–2026)
 Table 63. Global Semi-synthetic β-lactam Antibiotics Sales Market Share by Application (2027–2032)
 Table 64. Global Semi-synthetic β-lactam Antibiotics Revenue (US$ Million) by Application (2021–2026)
 Table 65. Global Semi-synthetic β-lactam Antibiotics Revenue (US$ Million) by Application (2027–2032)
 Table 66. Global Semi-synthetic β-lactam Antibiotics Revenue Market Share by Application (2021–2026)
 Table 67. Global Semi-synthetic β-lactam Antibiotics Revenue Market Share by Application (2027–2032)
 Table 68. Global Semi-synthetic β-lactam Antibiotics Price (US$/Ton) by Application (2021–2026)
 Table 69. Global Semi-synthetic β-lactam Antibiotics Price (US$/Ton) by Application (2027–2032)
 Table 70. GSK Company Information
 Table 71. GSK Description and Business Overview
 Table 72. GSK Semi-synthetic β-lactam Antibiotics Sales (Tons), Revenue (US$ Million), Price (US$/Ton), and Gross Margin (2021–2026)
 Table 73. GSK Semi-synthetic β-lactam Antibiotics Product
 Table 74. GSK Recent Developments/Updates
 Table 75. Novartis Company Information
 Table 76. Novartis Description and Business Overview
 Table 77. Novartis Semi-synthetic β-lactam Antibiotics Sales (Tons), Revenue (US$ Million), Price (US$/Ton), and Gross Margin (2021–2026)
 Table 78. Novartis Semi-synthetic β-lactam Antibiotics Product
 Table 79. Novartis Recent Developments/Updates
 Table 80. Centrient Pharma Company Information
 Table 81. Centrient Pharma Description and Business Overview
 Table 82. Centrient Pharma Semi-synthetic β-lactam Antibiotics Sales (Tons), Revenue (US$ Million), Price (US$/Ton), and Gross Margin (2021–2026)
 Table 83. Centrient Pharma Semi-synthetic β-lactam Antibiotics Product
 Table 84. Centrient Pharma Recent Developments/Updates
 Table 85. Teva Company Information
 Table 86. Teva Description and Business Overview
 Table 87. Teva Semi-synthetic β-lactam Antibiotics Sales (Tons), Revenue (US$ Million), Price (US$/Ton), and Gross Margin (2021–2026)
 Table 88. Teva Semi-synthetic β-lactam Antibiotics Product
 Table 89. Teva Recent Developments/Updates
 Table 90. Mylan Company Information
 Table 91. Mylan Description and Business Overview
 Table 92. Mylan Semi-synthetic β-lactam Antibiotics Sales (Tons), Revenue (US$ Million), Price (US$/Ton), and Gross Margin (2021–2026)
 Table 93. Mylan Semi-synthetic β-lactam Antibiotics Product
 Table 94. Mylan Recent Developments/Updates
 Table 95. Cipla Company Information
 Table 96. Cipla Description and Business Overview
 Table 97. Cipla Semi-synthetic β-lactam Antibiotics Sales (Tons), Revenue (US$ Million), Price (US$/Ton), and Gross Margin (2021–2026)
 Table 98. Cipla Semi-synthetic β-lactam Antibiotics Product
 Table 99. Cipla Recent Developments/Updates
 Table 100. Huayao International Company Information
 Table 101. Huayao International Description and Business Overview
 Table 102. Huayao International Semi-synthetic β-lactam Antibiotics Sales (Tons), Revenue (US$ Million), Price (US$/Ton), and Gross Margin (2021–2026)
 Table 103. Huayao International Semi-synthetic β-lactam Antibiotics Product
 Table 104. Huayao International Recent Developments/Updates
 Table 105. United Pharmaceuticals Company Information
 Table 106. United Pharmaceuticals Description and Business Overview
 Table 107. United Pharmaceuticals Semi-synthetic β-lactam Antibiotics Sales (Tons), Revenue (US$ Million), Price (US$/Ton), and Gross Margin (2021–2026)
 Table 108. United Pharmaceuticals Semi-synthetic β-lactam Antibiotics Product
 Table 109. United Pharmaceuticals Recent Developments/Updates
 Table 110. Sun Pharma Company Information
 Table 111. Sun Pharma Description and Business Overview
 Table 112. Sun Pharma Semi-synthetic β-lactam Antibiotics Sales (Tons), Revenue (US$ Million), Price (US$/Ton), and Gross Margin (2021–2026)
 Table 113. Sun Pharma Semi-synthetic β-lactam Antibiotics Product
 Table 114. Sun Pharma Recent Developments/Updates
 Table 115. Lukang Pharmaceuticals Company Information
 Table 116. Lukang Pharmaceuticals Description and Business Overview
 Table 117. Lukang Pharmaceuticals Semi-synthetic β-lactam Antibiotics Sales (Tons), Revenue (US$ Million), Price (US$/Ton), and Gross Margin (2021–2026)
 Table 118. Lukang Pharmaceuticals Semi-synthetic β-lactam Antibiotics Product
 Table 119. Lukang Pharmaceuticals Recent Developments/Updates
 Table 120. Hikma Company Information
 Table 121. Hikma Description and Business Overview
 Table 122. Hikma Semi-synthetic β-lactam Antibiotics Sales (Tons), Revenue (US$ Million), Price (US$/Ton), and Gross Margin (2021–2026)
 Table 123. Hikma Semi-synthetic β-lactam Antibiotics Product
 Table 124. Hikma Recent Developments/Updates
 Table 125. Dr. Reddy Company Information
 Table 126. Dr. Reddy Description and Business Overview
 Table 127. Dr. Reddy Semi-synthetic β-lactam Antibiotics Sales (Tons), Revenue (US$ Million), Price (US$/Ton), and Gross Margin (2021–2026)
 Table 128. Dr. Reddy Semi-synthetic β-lactam Antibiotics Product
 Table 129. Dr. Reddy Recent Developments/Updates
 Table 130. Harbin Pharmaceuticals Company Information
 Table 131. Harbin Pharmaceuticals Description and Business Overview
 Table 132. Harbin Pharmaceuticals Semi-synthetic β-lactam Antibiotics Sales (Tons), Revenue (US$ Million), Price (US$/Ton), and Gross Margin (2021–2026)
 Table 133. Harbin Pharmaceuticals Semi-synthetic β-lactam Antibiotics Product
 Table 134. Harbin Pharmaceuticals Recent Developments/Updates
 Table 135. Aurubindo Company Information
 Table 136. Aurubindo Description and Business Overview
 Table 137. Aurubindo Semi-synthetic β-lactam Antibiotics Sales (Tons), Revenue (US$ Million), Price (US$/Ton), and Gross Margin (2021–2026)
 Table 138. Aurubindo Semi-synthetic β-lactam Antibiotics Product
 Table 139. Aurubindo Recent Developments/Updates
 Table 140. Meiji Holdings Company Information
 Table 141. Meiji Holdings Description and Business Overview
 Table 142. Meiji Holdings Semi-synthetic β-lactam Antibiotics Sales (Tons), Revenue (US$ Million), Price (US$/Ton), and Gross Margin (2021–2026)
 Table 143. Meiji Holdings Semi-synthetic β-lactam Antibiotics Product
 Table 144. Meiji Holdings Recent Developments/Updates
 Table 145. DSM Company Information
 Table 146. DSM Description and Business Overview
 Table 147. DSM Semi-synthetic β-lactam Antibiotics Sales (Tons), Revenue (US$ Million), Price (US$/Ton), and Gross Margin (2021–2026)
 Table 148. DSM Semi-synthetic β-lactam Antibiotics Product
 Table 149. DSM Recent Developments/Updates
 Table 150. Changsheng Pharmaceuticals Company Information
 Table 151. Changsheng Pharmaceuticals Description and Business Overview
 Table 152. Changsheng Pharmaceuticals Semi-synthetic β-lactam Antibiotics Sales (Tons), Revenue (US$ Million), Price (US$/Ton), and Gross Margin (2021–2026)
 Table 153. Changsheng Pharmaceuticals Semi-synthetic β-lactam Antibiotics Product
 Table 154. Changsheng Pharmaceuticals Recent Developments/Updates
 Table 155. North China Pharmaceuticals Company Information
 Table 156. North China Pharmaceuticals Description and Business Overview
 Table 157. North China Pharmaceuticals Semi-synthetic β-lactam Antibiotics Sales (Tons), Revenue (US$ Million), Price (US$/Ton), and Gross Margin (2021–2026)
 Table 158. North China Pharmaceuticals Semi-synthetic β-lactam Antibiotics Product
 Table 159. North China Pharmaceuticals Recent Developments/Updates
 Table 160. Chuanning Biopharmaceuticals Company Information
 Table 161. Chuanning Biopharmaceuticals Description and Business Overview
 Table 162. Chuanning Biopharmaceuticals Semi-synthetic β-lactam Antibiotics Sales (Tons), Revenue (US$ Million), Price (US$/Ton), and Gross Margin (2021–2026)
 Table 163. Chuanning Biopharmaceuticals Semi-synthetic β-lactam Antibiotics Product
 Table 164. Chuanning Biopharmaceuticals Recent Developments/Updates
 Table 165. Weiqida Company Information
 Table 166. Weiqida Description and Business Overview
 Table 167. Weiqida Semi-synthetic β-lactam Antibiotics Sales (Tons), Revenue (US$ Million), Price (US$/Ton), and Gross Margin (2021–2026)
 Table 168. Weiqida Semi-synthetic β-lactam Antibiotics Product
 Table 169. Weiqida Recent Developments/Updates
 Table 170. Key Raw Materials Lists
 Table 171. Raw Materials Key Suppliers Lists
 Table 172. Semi-synthetic β-lactam Antibiotics Distributors List
 Table 173. Semi-synthetic β-lactam Antibiotics Customers List
 Table 174. Semi-synthetic β-lactam Antibiotics Market Trends
 Table 175. Semi-synthetic β-lactam Antibiotics Market Drivers
 Table 176. Semi-synthetic β-lactam Antibiotics Market Challenges
 Table 177. Semi-synthetic β-lactam Antibiotics Market Restraints
 Table 178. Research Programs/Design for This Report
 Table 179. Key Data Information from Secondary Sources
 Table 180. Key Data Information from Primary Sources
 Table 181. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Semi-synthetic β-lactam Antibiotics
 Figure 2. Global Semi-synthetic β-lactam Antibiotics Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Semi-synthetic β-lactam Antibiotics Market Share by Type: 2025 & 2032
 Figure 4. Penicillin and Its Derivatives Product Picture
 Figure 5. Cephalosporins Product Picture
 Figure 6. Other Product Picture
 Figure 7. Global Semi-synthetic β-lactam Antibiotics Market Value by Application (US$ Million), 2021–2032
 Figure 8. Global Semi-synthetic β-lactam Antibiotics Market Share by Application: 2025 & 2032
 Figure 9. Hospital
 Figure 10. Clinic
 Figure 11. Other
 Figure 12. Global Semi-synthetic β-lactam Antibiotics Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 13. Global Semi-synthetic β-lactam Antibiotics Market Size (US$ Million), 2021–2032
 Figure 14. Global Semi-synthetic β-lactam Antibiotics Sales (Tons), 2021–2032
 Figure 15. Global Semi-synthetic β-lactam Antibiotics Average Price (US$/Ton), 2021–2032
 Figure 16. Semi-synthetic β-lactam Antibiotics Report Years Considered
 Figure 17. Semi-synthetic β-lactam Antibiotics Sales Share by Manufacturers in 2025
 Figure 18. Global Semi-synthetic β-lactam Antibiotics Revenue Share by Manufacturers in 2025
 Figure 19. Top 5 and Top 10 Global Semi-synthetic β-lactam Antibiotics Players: Market Share by Revenue in Semi-synthetic β-lactam Antibiotics in 2025
 Figure 20. Semi-synthetic β-lactam Antibiotics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 21. Global Semi-synthetic β-lactam Antibiotics Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 22. North America Semi-synthetic β-lactam Antibiotics Sales Market Share by Country (2021–2032)
 Figure 23. North America Semi-synthetic β-lactam Antibiotics Revenue Market Share by Country (2021–2032)
 Figure 24. United States Semi-synthetic β-lactam Antibiotics Revenue Growth Rate (US$ Million), 2021–2032
 Figure 25. Canada Semi-synthetic β-lactam Antibiotics Revenue Growth Rate (US$ Million), 2021–2032
 Figure 26. Europe Semi-synthetic β-lactam Antibiotics Sales Market Share by Country (2021–2032)
 Figure 27. Europe Semi-synthetic β-lactam Antibiotics Revenue Market Share by Country (2021–2032)
 Figure 28. Germany Semi-synthetic β-lactam Antibiotics Revenue Growth Rate (US$ Million), 2021–2032
 Figure 29. France Semi-synthetic β-lactam Antibiotics Revenue Growth Rate (US$ Million), 2021–2032
 Figure 30. U.K. Semi-synthetic β-lactam Antibiotics Revenue Growth Rate (US$ Million), 2021–2032
 Figure 31. Italy Semi-synthetic β-lactam Antibiotics Revenue Growth Rate (US$ Million), 2021–2032
 Figure 32. Russia Semi-synthetic β-lactam Antibiotics Revenue Growth Rate (US$ Million), 2021–2032
 Figure 33. Asia Pacific Semi-synthetic β-lactam Antibiotics Sales Market Share by Region (2021–2032)
 Figure 34. Asia Pacific Semi-synthetic β-lactam Antibiotics Revenue Market Share by Region (2021–2032)
 Figure 35. China Semi-synthetic β-lactam Antibiotics Revenue Growth Rate (US$ Million), 2021–2032
 Figure 36. Japan Semi-synthetic β-lactam Antibiotics Revenue Growth Rate (US$ Million), 2021–2032
 Figure 37. South Korea Semi-synthetic β-lactam Antibiotics Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. India Semi-synthetic β-lactam Antibiotics Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. Australia Semi-synthetic β-lactam Antibiotics Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. China Taiwan Semi-synthetic β-lactam Antibiotics Revenue Growth Rate (US$ Million), 2021–2032
 Figure 41. Southeast Asia Semi-synthetic β-lactam Antibiotics Revenue Growth Rate (US$ Million), 2021–2032
 Figure 42. Latin America Semi-synthetic β-lactam Antibiotics Sales Market Share by Country (2021–2032)
 Figure 43. Latin America Semi-synthetic β-lactam Antibiotics Revenue Market Share by Country (2021–2032)
 Figure 44. Mexico Semi-synthetic β-lactam Antibiotics Revenue Growth Rate (US$ Million), 2021–2032
 Figure 45. Brazil Semi-synthetic β-lactam Antibiotics Revenue Growth Rate (US$ Million), 2021–2032
 Figure 46. Argentina Semi-synthetic β-lactam Antibiotics Revenue Growth Rate (US$ Million), 2021–2032
 Figure 47. Colombia Semi-synthetic β-lactam Antibiotics Revenue Growth Rate (US$ Million), 2021–2032
 Figure 48. Middle East and Africa Semi-synthetic β-lactam Antibiotics Sales Market Share by Country (2021–2032)
 Figure 49. Middle East and Africa Semi-synthetic β-lactam Antibiotics Revenue Market Share by Country (2021–2032)
 Figure 50. Turkey Semi-synthetic β-lactam Antibiotics Revenue Growth Rate (US$ Million), 2021–2032
 Figure 51. Saudi Arabia Semi-synthetic β-lactam Antibiotics Revenue Growth Rate (US$ Million), 2021–2032
 Figure 52. UAE Semi-synthetic β-lactam Antibiotics Revenue Growth Rate (US$ Million), 2021–2032
 Figure 53. Global Sales Market Share of Semi-synthetic β-lactam Antibiotics by Type (2021–2032)
 Figure 54. Global Revenue Market Share of Semi-synthetic β-lactam Antibiotics by Type (2021–2032)
 Figure 55. Global Semi-synthetic β-lactam Antibiotics Price (US$/Ton) by Type (2021–2032)
 Figure 56. Global Sales Market Share of Semi-synthetic β-lactam Antibiotics by Application (2021–2032)
 Figure 57. Global Revenue Market Share of Semi-synthetic β-lactam Antibiotics by Application (2021–2032)
 Figure 58. Global Semi-synthetic β-lactam Antibiotics Price (US$/Ton) by Application (2021–2032)
 Figure 59. Semi-synthetic β-lactam Antibiotics Value Chain
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano String

SIMILAR REPORTS